Wird geladen...
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment
This Review discusses the various types of non-coding oligonucleotides, which have garnered extensive interest as new alternatives for targeted cancer therapies over small molecule inhibitors and monoclonal antibodies. These oligonucleotides can target any hallmark of cancer, no longer limited to so...
Gespeichert in:
| Veröffentlicht in: | Cancer Treat Rev |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826844/ https://ncbi.nlm.nih.gov/pubmed/26930249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2016.02.005 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|